Janney Montgomery Scott’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $18.1M | Sell |
33,346
-1,758
| -5% | -$990K | 0.04% | 479 |
|
|
2026
Q1 | $20.8M | Buy |
35,104
+735
| +2% | +$366K | 0.05% | 344 |
|
|
2025
Q4 | $16.7M | Buy |
34,369
+25,398
| +283% | +$11.8M | 0.04% | 425 |
|
|
2025
Q3 | $3.76M | Sell |
8,971
-35
| -0.4% | -$11.8K | 0.01% | 1007 |
|
|
2025
Q2 | $2.59M | Sell |
9,006
-324
| -3% | -$96.8K | 0.01% | 1105 |
|
|
2025
Q1 | $2.88M | Sell |
9,330
-97
| -1% | -$33.2K | 0.01% | 1009 |
|
|
2024
Q4 | $3.33M | Buy |
9,427
+789
| +9% | +$290K | 0.01% | 937 |
|
|
2024
Q3 | $3.1M | Sell |
8,638
-304
| -3% | -$103K | 0.01% | 938 |
|
|
2024
Q2 | $2.85M | Sell |
8,942
-18
| -0.2% | -$4.76K | 0.01% | 937 |
|
|
2024
Q1 | $2.06M | Buy |
8,960
+201
| +2% | +$45.4K | 0.01% | 1149 |
|
|
2023
Q4 | $1.93M | Sell |
8,759
-50
| -0.6% | -$11.5K | 0.01% | 1124 |
|
|
2023
Q3 | $1.99M | Buy |
8,809
+1,279
| +17% | +$295K | 0.01% | 1030 |
|
|
2023
Q2 | $1.66M | Sell |
7,530
-512
| -6% | -$113K | 0.01% | 1165 |
|
|
2023
Q1 | $1.8M | Sell |
8,042
-106
| -1% | -$26.1K | 0.01% | 1028 |
|
|
2022
Q4 | $2.27M | Sell |
8,148
-1,328
| -14% | -$335K | 0.01% | 969 |
|
|
2022
Q3 | $1.98M | Buy |
9,476
+237
| +3% | +$53K | 0.01% | 969 |
|
|
2022
Q2 | $2.16M | Buy |
9,239
+178
| +2% | +$36.2K | 0.01% | 898 |
|
|
2022
Q1 | $1.63M | Sell |
9,061
-109
| -1% | -$20.8K | 0.01% | 1003 |
|
|
2021
Q4 | $1.98M | Sell |
9,170
-118
| -1% | -$23.2K | 0.01% | 994 |
|
|
2021
Q3 | $1.71M | Buy |
9,288
+2,117
| +30% | +$417K | 0.01% | 1016 |
|
|
2021
Q2 | $1.29M | Buy |
+7,171
| New | +$1.37M | 0.01% | 1152 |
|
|
2016
Q2 | – | Sell |
-3,097
| Closed | -$345K | – | 1145 |
|
|
2016
Q1 | $345K | Sell |
3,097
-297
| -9% | -$37.6K | 0.01% | 905 |
|
|
2015
Q4 | $532K | Buy |
+3,394
| New | +$494K | 0.01% | 790 |
|
|
2015
Q3 | – | Sell |
-10,372
| Closed | -$1.8M | – | 1470 |
|
|
2015
Q2 | $1.8M | Buy |
10,372
+14
| +0.1% | +$2.52K | 0.04% | 522 |
|
|
2015
Q1 | $1.79M | Buy |
10,358
+829
| +9% | +$126K | 0.03% | 618 |
|
|
2014
Q4 | $1.23M | Sell |
9,529
-4,703
| -33% | -$606K | 0.02% | 764 |
|
|
2014
Q3 | $1.83M | Buy |
+14,232
| New | +$1.47M | 0.04% | 565 |
|
|
2014
Q2 | – | Sell |
-18,570
| Closed | -$1.75M | – | 2256 |
|
|
2014
Q1 | $1.75M | Sell |
18,570
-195
| -1% | -$19.9K | 0.04% | 517 |
|
|
2013
Q4 | $2.12M | Sell |
18,765
-9,135
| -33% | -$824K | 0.06% | 411 |
|
|
2013
Q3 | $2.2M | Buy |
27,900
+720
| +3% | +$52.6K | 0.07% | 356 |
|
|
2013
Q2 | $1.79M | Buy |
+27,180
| New | +$1.75M | 0.19% | 131 |
|
Other funds holding UTHR
ACA
JT
Janney Montgomery Scott's UTHR Position: Q2 2026 in Review
Janney Montgomery Scott reduced its United Therapeutics (UTHR) stake by 5% in Q2 2026, selling an estimated $990K and leaving 33,346 shares worth $18.1M. The position accounts for 0.04% of the portfolio, ranked #479.
Janney Montgomery Scott first reported a position in UTHR in Q2 2013 and has held it in 31 quarters since. The position peaked at $20.8M in Q1 2026. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.
- Janney Montgomery Scott held 33,346 shares of United Therapeutics worth $18.1M as of Q2 2026.
- Janney Montgomery Scott sold 1,758 United Therapeutics shares in Q2 2026, an estimated $990K.
- United Therapeutics made up 0.04% of Janney Montgomery Scott's portfolio in Q2 2026, its #479 holding.
- Janney Montgomery Scott first reported a position in United Therapeutics in Q2 2013 and has held it in 31 quarters since.
- Janney Montgomery Scott's United Therapeutics position peaked at $20.8M in Q1 2026.
- 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.
Based on Janney Montgomery Scott's 13F filing for Q2 2026, filed 5 Aug 2026.